Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes

BACKGROUND: Ultra-fast-acting insulins, such as fast-acting insulin aspart (faster aspart), have pharmacokinetic properties that may be advantageous for patients using continuous subcutaneous insulin infusion (CSII), provided that they are compatible with and safe to use in CSII. METHODS: Randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Zijlstra, Eric, Demissie, Marek, Graungaard, Tina, Heise, Tim, Nosek, Leszek, Bode, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761985/
https://www.ncbi.nlm.nih.gov/pubmed/28918652
http://dx.doi.org/10.1177/1932296817730375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761985/
https://www.ncbi.nlm.nih.gov/pubmed/28918652
http://dx.doi.org/10.1177/1932296817730375

Ejemplares similares